Skip to content

Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).

Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12606000307505
Acronym
The FOREMOST trial
Enrollment
600
Registered
2001-03-06
Start date
1999-07-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Current methods of monitoring the well-being of the unborn baby during labour often result in concern about the unborn baby's health. This leads to delivery by caesarean section, forceps, or vacuum. These babies are usually found to be healthy once born, meaning that the operation was unnecessary. In this study, when an unborn baby appears to be distressed, half of the study participants will be allocated to continue with the current monitoring of the baby's heartbeat. The other half will have a new form of monitoring, fetal oxygen saturation monitoring, added. We will then determine whether the new form of monitoring makes a difference int he number of times women need to have a caesarian section, forceps or vacuum delivery.

Interventions

Duration of Study: July 1999 to September 2004. Experimental group receive conventional CTG monitoring plus fetal oxygen saturation monitoring using an internal fetal sensor. Nellcor N-400/FS14 Monitor Purpose: to determine whether the addition of fetal oximetry (oxygen values) to normal monitoring could help reduce the number of times caesarean sections, vacuum and forceps births were performed for concern about the well-being of the baby during labour.

Sponsors

Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
16 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

Women in labour at > or = 36 weeks gestation with a non-reasuring CTG pattern.

Exclusion criteria

Multiple gestation; non-vertex presentation; placenta praevia; abrnp? placenta; APH; fetal anomaly; known significant viral infection (eg HIV); contraindication to invasive fetal monitoring

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026